Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UPADACITINIB vs VALBENAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UPADACITINIB vs VALBENAZINE: Safety Overview

Metric UPADACITINIB VALBENAZINE
Total FAERS Reports 65,656 23,191
Deaths Reported 2,406 1,221
Death Rate 3.7% 5.3%
Hospitalizations 15,931 3,225
Average Patient Age 57.4 yrs 60.0 yrs
% Female Patients 71.2% 67.3%
FDA Approval Date Apr 26, 2024 Apr 11, 2017
Manufacturer AbbVie Inc. Neurocrine Biosciences, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription